missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. ACE/CD143 Mouse anti-Human, Clone: 9B9, Novus Biologicals™

ACE/CD143 Mouse anti-Human, Clone: 9B9, Novus Biologicals™

Mouse Monoclonal Antibody

253.00 EUR

Specifications

Antigen ACE/CD143
Clone 9B9
Concentration 0.2 mg/ml
Dilution ELISA
Applications ELISA
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18331683
View Documents
missing translation for 'viewProductCertificates'
Bio-Techne
NBP3-07854-20UG 		20 μg
253.00 EUR
20µg
Please to purchase this item. Need a web account? Register with us today!
Description

Description

ACE/CD143 Monoclonal specifically detects ACE/CD143 in Human samples. It is validated for ELISA.
Specifications

Specifications

ACE/CD143
0.2 mg/ml
ELISA
Unconjugated
Mouse
Human
ACE1angiotensin converting enzyme, somatic isoform, angiotensin I converting enzyme (peptidyl-dipeptidase A) 1, carboxycathepsin, CD143, CD143 antigen, DCP, DCP1angiotensin-converting enzyme, dipeptidyl carboxypeptidase 1, Dipeptidyl carboxypeptidase I, EC 3.2.1.-, EC 3.4.15.1, Kininase II, MGC26566, MVCD3, peptidase P, testicular ECA
Full-length recombinant human ACE/CD143 protein
Primary
Store at 4°C.
9B9
ELISA
Monoclonal
Purified
RUO
10 mM PBS with 0.05% BSA
1636
IgG1 κ
Protein A or G purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.